Christoph Gorgulla

Dr. Christoph Gorgulla is a Faculty Member and Principal Investigator in the Department of Structural Biology at St. Jude Children’s Research Hospital, where he leads the QAI4Bio (Quantum AI for Biology) Lab within the Center of Excellence for Data-Driven Discovery.

His mission is to transform how new medicines are discovered: faster, at lower cost, with better candidates that stand a higher chance of succeeding, and against targets long considered undruggable. His work bridges theory, implementation, and application, translating fundamental advances in artificial intelligence, quantum mechanics, and quantum computing into technologies for drug discovery and ultimately into experimentally validated molecules.

A central focus of his research is overcoming a longstanding tradeoff in computational drug discovery: the scale required to search the vast chemical space and the accuracy to predict molecular properties of interest. He is the creator of VirtualFlow and AdaptiveFlow, open-source platforms that computationally evaluate tens of billions of candidate molecules against disease-relevant proteins. His lab applies these approaches across biology, from the drivers of childhood cancer to the epigenetic regulators that govern how cells age.

Dr. Gorgulla’s training is highly interdisciplinary. He earned degrees in molecular biology with bioinformatics and in mathematics with quantum physics, followed by a PhD in quantum chemistry and computational drug discovery from Freie Universität Berlin, the Berlin Mathematical School, and the Max Planck Institute for Molecular Genetics. He completed his postdoctoral training at Harvard University with Gerhard Wagner, Arthur Jaffe, and Haribabu Arthanari.

His work has appeared in Nature and Nature Biotechnology and has been supported by Google and Amazon Web Services. He has been a Google Cloud Champion Innovator and a Konrad-Zuse Fellow and has mentored more than 30 students and postdoctoral fellows.